tiprankstipranks
Trending News
More News >
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market

Puma Biotechnology (PBYI) Income Statement

Compare
631 Followers

Puma Biotechnology Income Statement

Last quarter (Q4 2024), Puma Biotechnology's total revenue was $59.08M, a decrease of -18.15% from the same quarter last year. In Q4, Puma Biotechnology's net income was $19.30M. See Puma Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 230.47M$ 235.64M$ 228.00M$ 253.20M$ 225.10M
Gross Profit
$ 166.06M$ 172.96M$ 172.90M$ 189.50M$ 185.70M
Operating Expenses
$ 135.10M$ 140.31M$ 142.20M$ 188.20M$ 216.10M
Depreciation and Amortization
$ 11.52M$ 11.52M$ 8.92M$ 10.60M$ 7.20M
EBITDA
$ 48.08M$ 47.52M$ 20.97M$ -5.40M$ -38.54M
Operating Income
$ 30.97M$ 32.64M$ 23.70M$ -8.90M$ -30.40M
Other Income/Expenses
$ -6.87M$ -9.97M$ -23.26M$ -30.09M$ -29.39M
Pretax Income
$ 24.10M$ 22.67M$ 500.00K$ -28.80M$ -59.80M
Net Income
$ 30.28M$ 21.59M$ 912.00K$ -29.10M$ -60.00M
Per Share Metrics
Basic EPS
$ 0.62$ 0.46$ 0.02$ -0.72$ -1.52
Diluted EPS
$ 0.62$ 0.45$ 0.02$ -0.72$ -1.52
Weighted Average Shares Outstanding
48.65M 47.13M 44.67M 40.64M 39.58M
Weighted Average Shares Outstanding (Diluted)
49.10M 47.55M 44.93M 40.64M 39.58M
Currency in USD

Puma Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis